Teladoc shares surged 26.9% after Q3 revenue came in near the upper end of guidance and adjusted EBITDA exceeded guidance. BetterHelp also performed toward the high end of its revenue range, though management expects cash-pay challenges to continue.
Shares plunged nearly 30% as investors were disappointed by a revised downward revenue outlook driven by accelerated deceleration in BetterHelp’s cash pay users and network constraints limiting insurance growth.
Shares of Teladoc Health rose 8.6% post-earnings, with investor enthusiasm driven by top- and bottom-line results exceeding guidance and early traction in the shift of BetterHelp's model toward insurance coverage.